|
🐜
|
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
26 auth.
E. Shane,
D. Burr,
B. Abrahamsen,
R. Adler,
T. Brown,
A. Cheung,
F. Cosman,
J. Curtis,
R. Dell,
D. Dempster,
P. Ebeling,
T. Einhorn,
H. Genant,
P. Geusens,
K. Klaushofer,
...
J. Lane,
F. McKiernan,
Ross E. McKinney,
A. Ng,
J. Nieves,
R. O’Keefe,
S. Papapoulos,
T. Howe,
M. V. D. van der Meulen,
R. Weinstein,
M. Whyte
|
10 |
2011 |
10
🐜
|
|
🐜
|
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
27 auth.
E. Shane,
D. Burr,
P. Ebeling,
B. Abrahamsen,
R. Adler,
T. Brown,
A. Cheung,
F. Cosman,
J. Curtis,
R. Dell,
D. Dempster,
T. Einhorn,
H. Genant,
P. Geusens,
K. Klaushofer,
...
K. Koval,
J. Lane,
F. McKiernan,
Ross E. McKinney,
A. Ng,
J. Nieves,
R. O’Keefe,
S. Papapoulos,
H. T. Sen,
M. V. D. van der Meulen,
R. Weinstein,
M. Whyte
|
10 |
2010 |
10
🐜
|
|
🦁
|
Incidence of atypical nontraumatic diaphyseal fractures of the femur
9 auth.
R. Dell,
A. Adams,
D. Greene,
T. Funahashi,
S. Silverman,
E. Eisemon,
...
Hui Zhou,
R. Burchette,
S. Ott
|
8 |
2012 |
8
🦁
|
|
🐜
|
Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention
10 auth.
J. Eisman,
E. Bogoch,
R. Dell,
J. Harrington,
Ross E. McKinney,
A. McLellan,
...
P. Mitchell,
S. Silverman,
Rick Singleton,
E. Siris
|
8 |
2012 |
8
🐜
|
|
🐜
|
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research
27 auth.
E. Shane,
D. Burr,
P. Ebeling,
B. Abrahamsen,
R. Adler,
T. Brown,
A. Cheung,
F. Cosman,
J. Curtis,
R. Dell,
D. Dempster,
T. Einhorn,
H. Genant,
P. Geusens,
K. Klaushofer,
...
K. Koval,
J. Lane,
F. McKiernan,
Ross E. McKinney,
A. Ng,
J. Nieves,
R. O’Keefe,
S. Papapoulos,
H. T. Sen,
M. V. D. van der Meulen,
R. Weinstein,
M. Whyte
|
8 |
2011 |
8
🐜
|
|
🐜
|
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
8 auth.
D. Black,
Erik J. Geiger,
R. Eastell,
E. Vittinghoff,
Bonnie H. Li,
Denison S. Ryan,
...
R. Dell,
A. Adams
|
7 |
2020 |
7
🐜
|
|
🐜
|
Incidence and demography of femur fractures with and without atypical features
11 auth.
A. Feldstein,
D. Black,
N. Perrin,
A. G. Rosales,
Darin M. Friess,
D. Boardman,
...
R. Dell,
A. Santora,
J. Chandler,
M. Rix,
E. Orwoll
|
7 |
2012 |
7
🐜
|
|
🦁
|
Osteoporosis disease management: the role of the orthopaedic surgeon.
R. Dell,
D. Greene,
S. Schelkun,
Kathy M Williams
|
7 |
2008 |
7
🦁
|
|
🐜
|
Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older Adults
9 auth.
W. Finkle,
J. Der,
S. Greenland,
J. Adams,
Gregory K. Ridgeway,
Terrance Blaschke,
...
Zixia Wang,
R. Dell,
K. Vanriper
|
6 |
2011 |
6
🐜
|
|
🐬
|
Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization
R. Karim,
R. Dell,
D. Greene,
W. Mack,
J. Gallagher,
H. Hodis
|
6 |
2011 |
6
🐬
|
|
🦁
|
Osteoporosis disease management: What every orthopaedic surgeon should know.
R. Dell,
D. Greene,
David Anderson,
Kathy M Williams
|
6 |
2009 |
6
🦁
|
|
🐬
|
Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry
M. Khatod,
M. Inacio,
R. Dell,
S. Bini,
E. Paxton,
R. Namba
|
5 |
2015 |
5
🐬
|
